Cargando…

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients

Genetic testing for hereditary breast and ovarian cancer (HBOC) is recommended for breast cancer patients diagnosed at age ≤ 50 years. Our objective was to examine racial/ethnic differences in genetic testing frequency and results among diverse breast cancer patients. A retrospective cohort study am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, T, Trivedi, MS, Jiang, X, Silverman, T, Underhill, M, Chung, WK, Kukafka, R, Crew, KD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293107/ https://www.ncbi.nlm.nih.gov/pubmed/31802423 http://dx.doi.org/10.1007/s13187-019-01646-8

Ejemplares similares

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial
por: Jones, Tarsha, et al.
Publicado: (2021)

Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2‐negative individuals who had genetic testing in a large urban comprehensive cancer center
por: Tatineni, Sushma, et al.
Publicado: (2022)

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients
por: Culver, Julie O., et al.
Publicado: (2020)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation–Negative Breast Cancer
por: Park, Ji Soo, et al.
Publicado: (2022)

Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers
por: Jones, Tarsha, et al.
Publicado: (2022)

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
por: Leduc-Pessah, Heather, et al.
Publicado: (2022)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world
por: Ow, Samuel Guan Wei, et al.
Publicado: (2019)

Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting
por: Kukafka, Rita, et al.
Publicado: (2018)

Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care
por: Silverman, Thomas B., et al.
Publicado: (2018)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition
por: Tedaldi, Gianluca, et al.
Publicado: (2019)

Cognitive and emotional factors related to COVID-19 among high-risk ethnically diverse adults at the onset of the New York City outbreak: A cross-sectional survey
por: Kukafka, Rita, et al.
Publicado: (2023)

Clinical experience with multigene carrier panels in the reproductive setting
por: Terhaar, Catherine, et al.
Publicado: (2018)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
por: Wong, Edward S Y, et al.
Publicado: (2016)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
por: Tedaldi, Gianluca, et al.
Publicado: (2020)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
por: Valentini, Virginia, et al.
Publicado: (2023)

Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women
por: Kukafka, Rita, et al.
Publicado: (2015)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors’ and counselees’ views
por: Medendorp, Niki M., et al.
Publicado: (2018)

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
por: Calvello, Mariarosaria, et al.
Publicado: (2023)

Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders
por: Schuermans, Nika, et al.
Publicado: (2023)

Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
por: Liu, Yinfeng, et al.
Publicado: (2023)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
por: Dominguez-Valentin, Mev, et al.
Publicado: (2019)

Molecular diagnostic yield of genome sequencing versus targeted gene panel testing in racially and ethnically diverse pediatric patients
por: Abul-Husn, Noura S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hh5uh93c587sk47s4ojb699c57